WMU med school plans move forward with appointment of interim dean

Dr. Jack R. Luderer has been deeply involved in the development of Western Michigan University's medical school initiative. Now he's heading it up.

Luderer became interim dean effective June 1. He has served the past five years as executive director of WMU's Biosciences Research and Commercialization Center, a life-sciences research center that assists startup companies.  

A national search for a founding dean was launched in February. It will likely be several months before one will be in place to lead the school.

Luderer, a board-certified medical specialist in internal medicine with sub-specialty certification in clinical pharmacology, has a background that includes positions as a clinical vice president for Pharmacia Inc. and Upjohn and vice president for research at WMU.

In addition to serving in his BRCC role, he has spent the past two years working with WMU President John M. Dunn and the Kalamazoo medical community to develop a new school of medicine.

The Kalamazoo initiative has filed a letter of intent and has been awarded applicant status with the Liaison Committee on Medical Education, the group that accredits medical schools in the United States and Canada.

A school of medicine in Kalamazoo has been under discussion and in the planning stage since late 2007. During a November 2009 meeting, Dunn announced a $1.8 million anonymous gift made to provide seed money for the next steps in the development process, including the search for a dean.

Dunn says with this appointment Luderer's full attention will be on two goals: maintain existing momentum toward obtaining the money necessary to found the school and bringing the search for dean to a successful conclusion.
 
The initiative is collaboration with Kalamazoo's two major hospitals -- Borgess Health and Bronson Healthcare -- as well as other interested medical organizations in West Michigan.

Writer: Kathy Jennings
Source: Cheryl Roland, WMU
Enjoy this story? Sign up for free solutions-based reporting in your inbox each week.